The bovine high-mountain disease market is projected to grow from USD 5.0 billion in 2025 to USD 8.4 billion by 2035, at a CAGR of 5.2%. Bovine High-Mountain Disease Diuretics will dominate with a 45.0% market share, while bovine high-mountain disease drugs sales via veterinary hospitals will lead the distribution channel segment with a 40.0% share.